LYFAX Mutual Fund

LYFAX Mutual Fund

NAV$17.06
See how much of LYFAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 62 holdings · as of Jun 30, 2026
LYFAX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
GILD
Gilead SciencesHealth Care · Pharmaceuticals
5.53%		5.5%20,426$2.58MHealth CarePharmaceuticals
2—Nvaesrtex Pharmaceuticals IncHealth Care · Pharmaceuticals
5.33%		10.9%5,002$2.48MHealth CarePharmaceuticals
Share changes, sector and industry · Pro
3—Astrazeneca Plc
4.63%		15.5%11,394$2.16M
4
FXFXX
First Am Treas Obli-X
4.26%		19.8%-$1.99M
5—Roivant Sciences Ltd. Common Shares
3.67%		23.4%48,355$1.71M
6—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
3.59%		27.0%1,806$1.68M
7
INCY
Incyte Corp.
3.51%		30.5%14,451$1.64M
8
NBIX
Neurocrine Biosciences Inc
3.51%		34.0%9,727$1.64M
9
AXSM
Axsome Therapeutics Inc
3.43%		37.5%6,531$1.60M
10
ALLO
Allogene Therapeutics Inc
3.28%		40.7%11,533$1.53M
11—Ascendis Pharma A/S
2.62%		43.4%4,585$1.22M
12
IONS
Ionis Pharmaceuticals Inc
2.62%		46.0%15,430$1.22M
13
INSM
Insmed Inc
2.60%		48.6%11,394$1.21M
14
PTGX
Protagonist Therapeutics Inc
2.41%		51.0%9,171$1.12M
15
PSNL
Personalis Inc
2.27%		53.3%78,924$1.06M
16
RYTM
Rhythm Pharmaceuticals Inc
2.25%		55.5%9,449$1.05M
17
ABBV
AbbVie Inc.
1.95%		57.5%3,613$909.2K
18
JAZZ
Jazz Pharmaceuticals Plc.
1.87%		59.3%3,613$870.6K
19
AMGN
Amgen Inc.
1.83%		61.2%2,362$855.3K
20
BIIB
Biogen Inc.
1.80%		63.0%3,891$840.7K
21
CPARU
Catalyst Partners Acquisition Corp Ieu
1.59%		64.5%23,622$742.4K
22
HALO
Halozyme Therapeutics Inc
1.58%		66.1%9,426$737.8K
23—Meiragtx Holdings Plc Ordinary Shares
1.58%		67.7%54,469$735.9K
24
KRYS
Krystal Biotech Inc
1.55%		69.3%1,945$722.9K
25—Abivax Sa Sponsored Adr (1 Ads : 1 Ordinary)
1.47%		70.7%5,141$685.1K
26
NUVL
Nuvalent, Inc.
1.47%		72.2%5,558$686.4K
27
EWTX
Edgewise Therapeutics Inc.
1.38%		73.6%15,840$643.6K
28
NRIX
Nurix Therapeutics Inc
1.34%		74.9%25,845$627.0K
29
ORKA
Oruka Therapeutics Inc Orka
1.33%		76.2%6,531$621.6K
30—Sanofi Sponsored Adr (1 Ads : 0.5 Ordinary)
1.33%		77.6%14,590$622.4K
31
KYMR
Kymera Therapeutics Inc
1.32%		78.9%5,385$617.5K
32
SYRE
Spyre Therapeutics Inc
1.27%		80.2%6,670$592.2K
33—Biontech Se Adr
1.25%		81.4%6,266$583.1K
34
AGIO
Agios Pharmaceuticals Inc
1.13%		82.5%14,173$526.0K
35—Newamsterdam Pharma Nv
1.08%		83.6%14,868$503.9K
36
CYTK
Cytokinetics Inc
1.04%		84.7%5,697$485.3K
37
CLDX
Celldex Therapeutics Inc
1.02%		85.7%12,784$475.7K
38
TRVI
Trevi Therapeutics Inc.
0.97%		86.7%24,317$453.5K
39
ALNY
Alnylam Pharmaceuticals Inc.
0.90%		87.6%1,390$418.4K
40
VCYT
Veracyte, Inc.
0.87%		88.4%6,948$408.1K
41
CADL
Candel Therapeutics Inc.
0.81%		89.2%36,683$377.8K
42
NTRA
Natera Inc
0.81%		90.0%1,390$377.3K
43—Rezolute Inc Pipe Deal Rzlt
0.81%		90.9%72,255$375.7K
44—Cullinan Oncology Inc
0.80%		91.7%20,426$372.0K
45
CRNX
Crinetics Pharmaceuticals Inc
0.79%		92.4%9,866$369.2K
46—Xeris Pharmaceuticals Inc
0.79%		93.2%46,549$368.7K
47
DSGN
Design Therapeutics Inc.
0.67%		93.9%21,537$311.6K
48
GLUE
Monte Rosa Therapeutics Inc
0.66%		94.6%12,645$306.0K
49
IRON
Disc Medicine, Inc.
0.63%		95.2%4,030$294.8K
50
RAPP
Rapport Therapeutics, Inc.
0.58%		95.8%6,531$272.1K
More holdings · Pro
FundXLS Pro
See the other 12 holdings of LYFAX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

LYFAX Mutual Fund All Holdings

LYFAX holdings total 62 positions. The top 10 holdings account for 40.7% of the fund, led by Gilead Sciences at 5.5%, Nvaesrtex Pharmaceuticals Inc at 5.3%, Astrazeneca Plc at 4.6%.

LYFAX portfolio concentration is moderate, with the top 10 representing 40.7% of total assets. The largest sector exposure is Health Care at 87.7%.

LYFAX sectors provide a detailed breakdown. LYFAX overlap shows how holdings compare to other funds in your portfolio.